Studies of the hormonal regulation of type 2 5'-iodothyronine deiodinase messenger ribonucleic acid in pituitary tumor cells using semiquantitative reverse transcription-polymerase chain reaction

Endocrinology

Volumn 139, Issue 12, 1998, Pages 4895-4905

  Kim, Sung Woo ^a   Harney, John W ^a   Larsen, P Reed ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,3',5' TRIIODOTHYRONINE; 8 BROMO CYCLIC AMP; CYCLOPHILIN; DEXAMETHASONE; LIOTHYRONINE; MESSENGER RNA; PROTIRELIN; THYROXINE DEIODINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEEDBACK SYSTEM; HORMONAL REGULATION; HYPERTHYROIDISM; HYPOPHYSIS TUMOR; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

EID: 0031785516     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.12.6334     Document Type: Article

References (39)

1. Larsen PR, Berry MJ 1995 Nutritional and hormonal regulation of thyroid hormone deiodinases. Ann Rev Nutr 15:323-352
2. DeGroot LG, Larsen PR, Hennemann G 1996 Thyroid hormone transport, cellular uptake, metabolism, and molecular action. In: The Thyroid and Its Diseases. 6th ed. Churchill Livingstone, New York, Chapter 3, pp 61-111
3. Salvatore D, Bartha T, Harney JW, Larsen PR 1996 Molecular biological and biochemical characterization of the human Type 2 selenodeiodinase. Endocrinology 137:3308-3315
4. Salvatore D, Tu H, Hamey JW, Larsen PR 1996 Type 2 iodothyronine deiodinase is highly expressed in human thyroid. J Clin Invest 98:962-968
5. Croteau W, Davey JC, Galton VA, St. Germain DL 1996 Cloning of the mammalian type II iodothyronine deiodinase: a selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest 98:405-417
6. Silva JE, Larsen PR 1977 Pituitary nuclear 3,5,3′-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine. Science 198:617-620
7. Larsen PR, Dick TE, Markovitz MM, Kaplan MM, Gard TG 1979 Inhibition of intrapituitary thyroxine to 3,5,3′-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats. J Clin Invest 64:117-128
8. Silva JE, Kaplan MM, Cheron RG, Dick TE, Larsen PR 1978 Thyroxine to 3,5,3′-triiodothyronine conversion by rat anterior pituitary and rat. Metabolism 27:1601-1607
9. Cheron RG, Kaplan MM, Larsen PR 1979 Physiological and pharmacologic influences on thyroxine to 3,5,3′-triiodothyronine conversion and nuclear 3,5,3′-triiodothyronine binding in rat anterior pituitary. J Clin Invest 64:1402-1414
10. Visser TJ, Leonard JL, Kaplan MM, Larsen PR 1982 Kinetic evidence suggesting two mechanisms for iodothyronine 5′-deiodination in rat cerebral cortex. Proc Natl Acad Sci USA 79:5080-5084
11. Crantz FR, Silva JE, Larsen PR 1982 Analysis of the sources and quantity of 3,5,3′-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology 110:367-375
12. Tu HM, Kim SW, Salvatore D, Bartha T, Legradi G, Larsen PR, Lechan RM 1997 Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 138:3359-3368
13. Guadano-Ferraz A, Obregon MJ, St. Germain DL, Bernal J 1997 The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. Proc Natl Acad Sci USA 94:10391-10396
14. Riskind PN, Kolodny JM, Larsen PR 1987 The regional hypothalamic distribution of type II 5′-monodeiodinase in euthyroid and hypothyroid rats. Brain Res 420:194-198
15. Leonard JL, Silva JE, Kaplan MM, Mellen SA, Visser TJ, Larsen PR 1984 Acute post-transcriptional regulation of cerebrocortical and pituitary iodothyroinine 5′-deiodinase by thyroid hormone. Endocrinology 114:998-1004
16. Silva JE, Leonard JL 1985 Regulation of rat cerebrocortical and adenohypophyseal type II 5′-deiodinase by thyroxine, triiodothyronine, and reverse triiodothyronine. Endocrinology 116:1627-1635
17. St. Germain D 1988 The effects and interactions of substrates, inhibitors, and the cellular thiol-disulfide balance on the regulation of type II iodothyronine 5′-deiodinase. Endocrinology 122:1860-1868
18. Burmeister LA, Pachucki J, St. Germain DL 1997 Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms. Endocrinology 138:5231-5237
19. Kim SW, Ahn IM, Larsen PR 1996 In vivo genomic footprinting of thyroid hormone-responsive genes in pituitary tumor cell lines. Mol Cell Biol 16:4465-4477
20. Berry MJ, Kates AL, Larsen PR 1990 Thyroid hormone regulates type I deiodinase messenger RNA in rat liver. Mol Endocrinol 4:743-748
21. Lehrach H, Diamond D, Wozney JM, Boedtker H 1977 RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry 16:4743-4751
22. Danielson PE, Forss-Petter S, Brow MA, Calavetta L, Douglass J, Milner RJ, Sutcliffe JG 1988 p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA 7:261-267
23. Henley WN, Schuebel KE, Nielsen DA 1996 Limitations imposed by heteroduplex formation on quantitative RT-PCR. Biochem Biophys Res Commun 226:113-117
24. Obregon MJ, Larsen PR, Silva JE 1986 The role of 3,3′5′-trriiodothyronine in the regulation of Type II iodothyronine 5′-deiodinase in the rat cerebral cortex. Endocrinology 119:2186-2192
25. Halperin Y, Shapiro LE, Surks MI 1994 Down-regulation of type II L-thyroxine, ′-monodeiodinase in cultured GC cells: different pathways of regulation by L-triiodothyronine and 3,3′,5′-triiodo-L-thyronine. Endocrinology 135:1464-1469
26. St. Germain DL 1986 Hormonal control of a low Km (type II) iodothyronine 5′-deiodinase in cultured NB41A3 mouse neuroblastoma cells. Endocrinology 119:840-846
27. Koenig RJ 1986 Regulation of thyroxine 5′-deiodinase by thyroid hormones and activators of protein kinase C in GH4C1 cells. Endocrinology 118:1491-1497
28. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA 1995 An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 270:12953-12956
29. Araki N, Robinson FD, Nishimoto SK 1993 Rapid and sensitive method of quantitation of bone gla protein mRNA using competitive polymerase chain reaction. J Bone Miner Res 8:313-322
30. Maia AL, Harney JW, Larsen PR 1995 Pituitary cells respond to thyroid hormone by discrete, gene-specific pathways. Endocrinology 136:1488-1494
31. Gard TG, Bernstein B, Larsen PR 1981 Studies on the mechanism of 3,5,3′-triiodothyronine-induced suppression of secretagogue-induced thyrotropin release in vitro. Endocrinology 108:2046-2053
32. Shupnik MA, Chin WW, Habener JF, Ridgway EC 1985 Transcriptional regulation of the thyrotropin subunit genes by thyroid hormone. J Biol Chem 260:2900-2903
33. 3 in cultured rat anterior pituitary cells. Endocrinology 115:324-329
34. Courtin F, Chantoux F, Gavaret J-M, Toru-Delbauffe D, Jacquemin C, Pierre M 1989 Induction of Type II 5′-deiodinase activity in cultured rat astroglial cells by 12-O-tetradecanoylphorbol-13-acetate: dependence on glucocorticoids. Endocrinology 125:1277-1281
35. 3 administration. Metabolism 36:799-803
36. Cavalier RR, Gavin LA, Cole R, De Vellis J 1986 Thyroid hormone deiodinases iri purified primary glial cell cultures. Brain Res 364:382-385
37. Morley JE 1981 Neuroendocrine control of thyrotropin secretion. Endocr Rev 2:396-436
38. Leonard JL 1988 Dibutyryl cAMP induction of Type II 5′deiodinase activity in rat brain astrocytes in culture. Biochem Biophys Res Comm 151:1164-1172
39. Mills I, Raasmaja A, Moolten N, Lemack G, Silva JE, Larsen PR 1989 Effect of thyroid status on catecholamine stimulation of thyroxine 5′-deiodinase in isolated brown adipocytes. Am J Physiol 256:E74-E79